{"id":46428,"date":"2022-07-21T14:02:06","date_gmt":"2022-07-21T12:02:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/"},"modified":"2022-07-21T14:02:06","modified_gmt":"2022-07-21T12:02:06","slug":"cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/","title":{"rendered":"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022"},"content":{"rendered":"
\n

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2022 financial results will be released on Thursday, August 4, 2022, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company\u2019s financial results and provide a general business overview and outlook.\n<\/p>\n

<\/a><\/p>\n

\nTo listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http:\/\/ir.cerus.com. Participants may register for the call here<\/a>. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event.\n<\/p>\n

\nA replay will be available on Cerus\u2019 website and will be available approximately three hours after the call through August 18, 2022.\n<\/p>\n

\nABOUT CERUS<\/b>\n<\/p>\n

\nCerus Corporation is dedicated solely to safeguarding the world\u2019s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of INTERCEPT Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. For more information about Cerus, visit www.cerus.com<\/a> and follow us on LinkedIn.\n<\/p>\n

\nINTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMatt Notarianni \u2013 Senior Director, Investor Relations
\n
Cerus Corporation
\n
925-288-6137\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2022 financial results will be released on Thursday, August 4, 2022, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company\u2019s financial results and … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46428","6":"format-standard","7":"category-industry"},"yoast_head":"\nCerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2022 financial results will be released on Thursday, August 4, 2022, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company\u2019s financial results and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-21T12:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220721005002\/en\/724993\/21\/cerus_210x60.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022\",\"datePublished\":\"2022-07-21T12:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/\"},\"wordCount\":316,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005002\\\/en\\\/724993\\\/21\\\/cerus_210x60.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/\",\"name\":\"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005002\\\/en\\\/724993\\\/21\\\/cerus_210x60.jpg\",\"datePublished\":\"2022-07-21T12:02:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005002\\\/en\\\/724993\\\/21\\\/cerus_210x60.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220721005002\\\/en\\\/724993\\\/21\\\/cerus_210x60.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/","og_locale":"en_US","og_type":"article","og_title":"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022 - Pharma Trend","og_description":"CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2022 financial results will be released on Thursday, August 4, 2022, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company\u2019s financial results and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-21T12:02:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220721005002\/en\/724993\/21\/cerus_210x60.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022","datePublished":"2022-07-21T12:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/"},"wordCount":316,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721005002\/en\/724993\/21\/cerus_210x60.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/","url":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/","name":"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220721005002\/en\/724993\/21\/cerus_210x60.jpg","datePublished":"2022-07-21T12:02:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220721005002\/en\/724993\/21\/cerus_210x60.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220721005002\/en\/724993\/21\/cerus_210x60.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cerus-corporation-to-release-second-quarter-2022-financial-results-on-august-4-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cerus Corporation to Release Second Quarter 2022 Financial Results on August 4, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46428","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46428"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46428\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}